Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

W.B. Pope; A. Lai; R. Mehta; H.J. Kim; J. Qiao; J.R. Young; X. Xue; J. Goldin; M.S. Brown; P.L. Nghiemphu; A. Tran; T.F. Cloughesy

doi:10.3174/ajnr.A2385

Research ArticleBrain

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

W.B. Pope, A. Lai, R. Mehta, H.J. Kim, J. Qiao, J.R. Young, X. Xue, J. Goldin, M.S. Brown, P.L. Nghiemphu, A. Tran and T.F. Cloughesy

American Journal of Neuroradiology May 2011, 32 (5) 882-889; DOI: https://doi.org/10.3174/ajnr.A2385

W.B. Pope

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

A. Lai

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

R. Mehta

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H.J. Kim

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J. Qiao

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J.R. Young

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

X. Xue

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J. Goldin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

M.S. Brown

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

P.L. Nghiemphu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

A. Tran

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

T.F. Cloughesy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
Responses
References
PDF

Article Information

vol. 32 no. 5 882-889

DOI

https://doi.org/10.3174/ajnr.A2385

PubMed

21330401

Published By

American Journal of Neuroradiology

Print ISSN

0195-6108

Online ISSN

1936-959X

History

Received July 15, 2010
Accepted after revision September 9, 2010
Published online May 13, 2011.

Author Information

W.B. Popea,
A. Laib,
R. Mehtaa,
H.J. Kima,
J. Qiaoa,
J.R. Younga,
X. Xuea,
J. Goldina,
M.S. Browna,
P.L. Nghiemphub,
A. Tranb and
T.F. Cloughesyb

^aFrom the Departments of Radiological Sciences (W.B.P., R.M., H.J.K., J.Q., J.R.Y., X.X., J.G., M.S.B.)
^bNeurology (A.L., P.L.N., A.T., T.F.C.), David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.

Please address correspondence to Whitney B. Pope, MD, PhD, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, BL-428 CHS, Los Angeles, CA 90095-1721; e-mail: wpope{at}mednet.ucla.edu

View Full Text

Altmetrics

Cited By...

154 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging

Nathan S. White, Carrie R. McDonald, Niky Farid, Josh Kuperman, David Karow, Natalie M. Schenker-Ahmed, Hauke Bartsch, Rebecca Rakow-Penner, Dominic Holland, Ahmed Shabaik, Atle Bjørnerud, Tuva Hope, Jona Hattangadi-Gluth, Michael Liss, J. Kellogg Parsons, Clark C. Chen, Steve Raman, Daniel Margolis, Robert E. Reiter, Leonard Marks, Santosh Kesari, Arno J. Mundt, Christopher J. Kane, Bob S. Carter, William G. Bradley, Anders M. Dale

Cancer Research 2014 74 17
Imaging Correlates of Adult Glioma Genotypes

Marion Smits, Martin J. van den Bent

Radiology 2017 284 2
Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

Christine Lu-Emerson, Dan G. Duda, Kyrre E. Emblem, Jennie W. Taylor, Elizabeth R. Gerstner, Jay S. Loeffler, Tracy T. Batchelor, Rakesh K. Jain

Journal of Clinical Oncology 2015 33 10
Quantifying heterogeneity in human tumours using MRI and PET

Marie-Claude Asselin, James P.B. O’Connor, Ronald Boellaard, Neil A. Thacker, Alan Jackson

European Journal of Cancer 2012 48 4
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI

S. Wang, M. Martinez-Lage, Y. Sakai, S. Chawla, S.G. Kim, M. Alonso-Basanta, R.A. Lustig, S. Brem, S. Mohan, R.L. Wolf, A. Desai, H. Poptani

American Journal of Neuroradiology 2016 37 1
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T

Daniel Paech, Johannes Windschuh, Johanna Oberhollenzer, Constantin Dreher, Felix Sahm, Jan-Eric Meissner, Steffen Goerke, Patrick Schuenke, Moritz Zaiss, Sebastian Regnery, Sebastian Bickelhaupt, Philipp Bäumer, Martin Bendszus, Wolfgang Wick, Andreas Unterberg, Peter Bachert, Mark Edward Ladd, Heinz-Peter Schlemmer, Alexander Radbruch

Neuro-Oncology 2018 20 12
Relationship Between Imaging Biomarkers of Stage I Cervical Cancer and Poor-Prognosis Histologic Features: Quantitative Histogram Analysis of Diffusion-Weighted MR Images

Kate Downey, Sophie F. Riches, Veronica A. Morgan, Sharon L. Giles, Ayoma D. Attygalle, Tom E. Ind, Desmond P. J. Barton, John H. Shepherd, Nandita M. deSouza

American Journal of Roentgenology 2013 200 2
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas

Kevin Leu, Garrett A. Ott, Albert Lai, Phioanh L. Nghiemphu, Whitney B. Pope, William H. Yong, Linda M. Liau, Timothy F. Cloughesy, Benjamin M. Ellingson

Journal of Neuro-Oncology 2017 134 1
Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma

Yi‐bin Xi, Fan Guo, Zi‐liang Xu, Chen Li, Wei Wei, Ping Tian, Ting‐ting Liu, Lin Liu, Gang Chen, Jing Ye, Guang Cheng, Long‐biao Cui, Hong‐juan Zhang, Wei Qin, Hong Yin

Journal of Magnetic Resonance Imaging 2018 47 5
Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics

Benjamin M. Ellingson

Current Neurology and Neuroscience Reports 2015 15 1
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI

Elizabeth R. Gerstner, Zheng Zhang, James R. Fink, Mark Muzi, Lucy Hanna, Erin Greco, Melissa Prah, Kathleen M. Schmainda, Akiva Mintz, Lale Kostakoglu, Edward A. Eikman, Benjamin M. Ellingson, Eva-Maria Ratai, A. Gregory Sorensen, Daniel P. Barboriak, David A. Mankoff

Clinical Cancer Research 2016 22 20
Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume

Yoon Seong Choi, Sung Soo Ahn, Seung-Koo Lee, Jong Hee Chang, Seok-Gu Kang, Se Hoon Kim, Jinyuan Zhou

European Radiology 2017 27 8
Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab

Ken Chang, Biqi Zhang, Xiaotao Guo, Min Zong, Rifaquat Rahman, David Sanchez, Nicolette Winder, David A Reardon, Binsheng Zhao, Patrick Y. Wen, Raymond Y Huang

Neuro-Oncology 2016 18 12
Pediatric Brain Tumor Genetics: What Radiologists Need to Know

Jehan AlRayahi, Michal Zapotocky, Vijay Ramaswamy, Prasad Hanagandi, Helen Branson, Walid Mubarak, Charles Raybaud, Suzanne Laughlin

RadioGraphics 2018 38 7
18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab

R. J. Harris, T. F. Cloughesy, W. B. Pope, P. L. Nghiemphu, A. Lai, T. Zaw, J. Czernin, M. E. Phelps, W. Chen, B. M. Ellingson

Neuro-Oncology 2012 14 8
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome

Shadi Lalezari, Arthur P. Chou, Anh Tran, Orestes E. Solis, Negar Khanlou, Weidong Chen, Sichen Li, Jose A. Carrillo, Reshmi Chowdhury, Julia Selfridge, Desiree E. Sanchez, Ryan W. Wilson, Mira Zurayk, Jonathan Lalezari, Jerry J. Lou, Laurel Ormiston, Karen Ancheta, Robert Hanna, Paul Miller, David Piccioni, Benjamin M. Ellingson, Colin Buchanan, Paul S. Mischel, Phioanh L. Nghiemphu, Richard Green, He-Jing Wang, Whitney B. Pope, Linda M. Liau, Robert M. Elashoff, Timothy F. Cloughesy, William H. Yong, Albert Lai

Neuro-Oncology 2013 15 3
Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma

Myriam M. Chaumeil, Tomoko Ozawa, IlWoo Park, Kristen Scott, C. David James, Sarah J. Nelson, Sabrina M. Ronen

NeuroImage 2012 59 1
Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma

Antonio Omuro, Kathryn Beal, Philip Gutin, Sasan Karimi, Denise D. Correa, Thomas J. Kaley, Lisa M. DeAngelis, Timothy A. Chan, Igor T. Gavrilovic, Craig Nolan, Adilia Hormigo, Andrew B. Lassman, Ingo Mellinghoff, Christian Grommes, Anne S. Reiner, Katherine S. Panageas, Raymond E. Baser, Viviane Tabar, Elena Pentsova, Juan Sanchez, Renata Barradas-Panchal, Jianan Zhang, Geraldine Faivre, Cameron W. Brennan, Lauren E. Abrey, Jason T. Huse

Clinical Cancer Research 2014 20 19
Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis

Yu Han, Lin-Feng Yan, Xi-Bin Wang, Ying-Zhi Sun, Xin Zhang, Zhi-Cheng Liu, Hai-Yan Nan, Yu-Chuan Hu, Yang Yang, Jin Zhang, Ying Yu, Qian Sun, Qiang Tian, Bo Hu, Gang Xiao, Wen Wang, Guang-Bin Cui

BMC Cancer 2018 18 1
True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram Analysis

Yong Sub Song, Seung Hong Choi, Chul-Kee Park, Kyung Sik Yi, Woong Jae Lee, Tae Jin Yun, Tae Min Kim, Se-Hoon Lee, Ji-Hoon Kim, Chul-Ho Sohn, Sung-Hye Park, Il Han Kim, Geon-Ho Jahng, Kee-Hyun Chang

Korean Journal of Radiology 2013 14 4
Emerging Biomarkers in Glioblastoma

Mairéad McNamara, Solmaz Sahebjam, Warren Mason

Cancers 2013 5 3
Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging

Sung Soo Ahn, Na-Young Shin, Jong Hee Chang, Se Hoon Kim, Eui Hyun Kim, Dong Wook Kim, Seung-Koo Lee

Journal of Neurosurgery 2014 121 2
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma

Mark S. Shiroishi, Jerrold L. Boxerman, Whitney B. Pope

Neuro-Oncology 2016 18 4
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma

Whitney B. Pope, Garth Brandal

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 62 3
Diffusion MRI in early cancer therapeutic response assessment

C. J. Galbán, B. A. Hoff, T. L. Chenevert, B. D. Ross

NMR in Biomedicine 2017 30 3
Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases

He-Yue Liang, Ya-Qin Huang, Zhao-Xia Yang, Ying-Ding, Meng-Su Zeng, Sheng-Xiang Rao

European Radiology 2016 26 7
Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

B. M. Ellingson, S. Sahebjam, H. J. Kim, W. B. Pope, R. J. Harris, D. C. Woodworth, A. Lai, P. L. Nghiemphu, W. P. Mason, T. F. Cloughesy

American Journal of Neuroradiology 2014 35 4
Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images

Peter D. Chang, Daniel S. Chow, Peter H. Yang, Christopher G. Filippi, Angela Lignelli

American Journal of Roentgenology 2017 208 1
Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium

Tina Young Poussaint, Sridhar Vajapeyam, Kelsey I. Ricci, Ashok Panigrahy, Mehmet Kocak, Larry E. Kun, James M. Boyett, Ian F. Pollack, Maryam Fouladi

Neuro-Oncology 2016 18 5
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas

A. Hilario, J. M. Sepulveda, A. Perez-Nunez, E. Salvador, J. M. Millan, A. Hernandez-Lain, V. Rodriguez-Gonzalez, A. Lagares, A. Ramos

American Journal of Neuroradiology 2014 35 6
Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics

Shanshan Jiang, Qihong Rui, Yu Wang, Hye-Young Heo, Tianyu Zou, Hao Yu, Yi Zhang, Xianlong Wang, Yongxing Du, Xinrui Wen, Fangyao Chen, Jihong Wang, Charles G. Eberhart, Jinyuan Zhou, Zhibo Wen

European Radiology 2018 28 5
Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma

Yoon Seong Choi, Sung Soo Ahn, Dong Wook Kim, Jong Hee Chang, Seok-Gu Kang, Eui Hyun Kim, Se Hoon Kim, Tyler Hyungtaek Rim, Seung-Koo Lee

Radiology 2016 281 1
Radiology’s Value Chain

Dieter R. Enzmann

Radiology 2012 263 1
Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors?

James P.B. O'Connor, Gordon C. Jayson

Clinical Cancer Research 2012 18 24
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

M. Hutterer, E. Hattingen, C. Palm, M. A. Proescholdt, P. Hau

Neuro-Oncology 2015 17 6
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study

S. Gururangan, J. Fangusaro, T. Young Poussaint, A. Onar-Thomas, R. J. Gilbertson, S. Vajapeyam, A. Gajjar, S. Goldman, H. S. Friedman, R. J. Packer, J. M. Boyett, L. E. Kun

Neuro-Oncology 2012 14 11
Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma

Yi Cui, Shangjie Ren, Khin Khin Tha, Jia Wu, Hiroki Shirato, Ruijiang Li

European Radiology 2017 27 9
Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma—Foundations and Future

Gayle R. Salama, Linda A. Heier, Praneil Patel, Rohan Ramakrishna, Rajiv Magge, Apostolos John Tsiouris

Frontiers in Neurology 2018 8
Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS‐MLPA in patients with glioblastoma multiforme

Leonard Sunwoo, Seung Hong Choi, Chul‐Kee Park, Jin Wook Kim, Kyung Sik Yi, Woong Jae Lee, Tae Jin Yoon, Sang Woo Song, Ja Eun Kim, Ji Young Kim, Tae Min Kim, Se‐Hoon Lee, Ji‐Hoon Kim, Chul‐Ho Sohn, Sung‐Hye Park, Il Han Kim, Kee‐Hyun Chang

Journal of Magnetic Resonance Imaging 2013 37 2
Histogram Analysis of Apparent Diffusion Coefficient Maps for Differentiating Primary CNS Lymphomas From Tumefactive Demyelinating Lesions

Shan Shan Lu, Sang Joon Kim, Namkug Kim, Ho Sung Kim, Choong Gon Choi, Young Min Lim

American Journal of Roentgenology 2015 204 4
Histogram Analysis of Apparent Diffusion Coefficient at 3.0 T in Urinary Bladder Lesions

Shi-Teng Suo, Xiao-Xi Chen, Yu Fan, Lian-Ming Wu, Qiu-Ying Yao, Meng-Qiu Cao, Qiang Liu, Jian-Rong Xu

Academic Radiology 2014 21 8
Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma

Peter S. LaViolette, Alex D. Cohen, Melissa A. Prah, Scott D. Rand, Jennifer Connelly, Mark. G. Malkin, Wade. M. Mueller, Kathleen M. Schmainda

Neuro-Oncology 2013 15 4
Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors

Francesco Sanvito, Antonella Castellano, Andrea Falini

Cancers 2021 13 3
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab

Qiuting Wen, Laleh Jalilian, Janine M. Lupo, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael Prados, Sarah J. Nelson

Journal of Neuro-Oncology 2015 121 2
Histogram-Based Apparent Diffusion Coefficient Analysis: An Emerging Tool for Cervical Cancer Characterization?

Andrew B. Rosenkrantz

American Journal of Roentgenology 2013 200 2
Radiomics for precision medicine in glioblastoma

Kiran Aftab, Faiqa Binte Aamir, Saad Mallick, Fatima Mubarak, Whitney B. Pope, Tom Mikkelsen, Jack P. Rock, Syed Ather Enam

Journal of Neuro-Oncology 2022 156 2
Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data

Min Ho Lee, Junhyung Kim, Sung-Tae Kim, Hye-Mi Shin, Hye-Jin You, Jung Won Choi, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee, Doo-Sik Kong

World Neurosurgery 2019 125
Differentiation between high and low grade tumours in paediatric patients by using apparent diffusion coefficients

Luciana Porto, Alina Jurcoane, Dirk Schwabe, Matthias Kieslich, Elke Hattingen

European Journal of Paediatric Neurology 2013 17 3
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas

Ziren Kong, Chengrui Yan, Ruizhe Zhu, Jiaru Wang, Yaning Wang, Yu Wang, Renzhi Wang, Feng Feng, Wenbin Ma

NeuroImage: Clinical 2018 20
The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival

Y.S. Choi, D.W. Kim, S.-K. Lee, J.H. Chang, S.-G. Kang, E.H. Kim, S.H. Kim, T.H. Rim, S.S. Ahn

American Journal of Neuroradiology 2015 36 12
Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method

Dayle Rundle‐Thiele, Bryan Day, Brett Stringer, Michael Fay, Jennifer Martin, Rosalind L. Jeffree, Paul Thomas, Christopher Bell, Olivier Salvado, Yaniv Gal, Alan Coulthard, Stuart Crozier, Stephen Rose

Journal of Medical Radiation Sciences 2015 62 2
Detection of glioblastoma response to temozolomide combined with bevacizumab based on µMRI and µPET imaging reveals [18F]-fluoro-l-thymidine as an early and robust predictive marker for treatment efficacy

Aurélien Corroyer-Dulmont, Elodie A. Pérès, Edwige Petit, Jean-Sébastien Guillamo, Nathalie Varoqueaux, Simon Roussel, Jérôme Toutain, Didier Divoux, Eric T. MacKenzie, Jérôme Delamare, Méziane Ibazizène, Myriam Lecocq, Andréas H. Jacobs, Louisa Barré, Myriam Bernaudin, Samuel Valable

Neuro-Oncology 2013 15 1
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma

N Bharwani, M E Miquel, T Powles, P Dilks, A Shawyer, A Sahdev, P D Wilson, S Chowdhury, D M Berney, A G Rockall

British Journal of Cancer 2014 110 3
Assessment and treatment relevance in elderly glioblastoma patients

L. Bauchet, S. Zouaoui, A. Darlix, N. Menjot de Champfleur, E. Ferreira, M. Fabbro, C. Kerr, L. Taillandier

Neuro-Oncology 2014 16 11
Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium

Katherine A. Zukotynski, Sridhar Vajapeyam, Frederic H. Fahey, Mehmet Kocak, Douglas Brown, Kelsey I. Ricci, Arzu Onar-Thomas, Maryam Fouladi, Tina Young Poussaint

Journal of Nuclear Medicine 2017 58 8
Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation

Ra Gyoung Yoon, Ho Sung Kim, Wooyul Paik, Woo Hyun Shim, Sang Joon Kim, Jeong Hoon Kim

European Radiology 2017 27 1
Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme

Xin Chen, Mengjie Fang, Di Dong, Lingling Liu, Xiangdong Xu, Xinhua Wei, Xinqing Jiang, Lei Qin, Zaiyi Liu

Academic Radiology 2019 26 10
Location of brain tumor intersecting white matter tracts predicts patient prognosis

Nikolai J. Mickevicius, Alexander B. Carle, Trevor Bluemel, Stephanie Santarriaga, Fallon Schloemer, Derrick Shumate, Jennifer Connelly, Kathleen M. Schmainda, Peter S. LaViolette

Journal of Neuro-Oncology 2015 125 2
Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report

Soichiro Yoshida, Shuichiro Kobayashi, Fumitaka Koga, Junichiro Ishioka, Chikako Ishii, Hiroshi Tanaka, Yasukazu Nakanishi, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Hitoshi Masuda, Yasuhisa Fujii, Kazunori Kihara

European Radiology 2013 23 8
Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients

Myron Zhang, Bryanna Gulotta, Alissa Thomas, Thomas Kaley, Sasan Karimi, Igor Gavrilovic, Kaitlin M. Woo, Zhigang Zhang, Julio Arevalo-Perez, Andrei I. Holodny, Marc Rosenblum, Robert J. Young

Neuro-Oncology 2016 18 5
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?

Maximilian Niyazi, Patrick N. Harter, Elke Hattingen, Maya Rottler, Louisa von Baumgarten, Martin Proescholdt, Claus Belka, Kirsten Lauber, Michel Mittelbronn

Oncotarget 2016 7 3
Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials

Shou-Bo Yang, Kai-Di Gao, Tao Jiang, Shu-Jun Cheng, Wen-Bin Li

Oncotarget 2017 8 34
The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI‐derived and clinical features, predict adult primary glioblastoma survival

Chang Shu, Qiong Wang, Xiaoling Yan, Jinhuan Wang

Cancer Medicine 2018 7 8
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma

Anahita Fathi Kazerooni, Hamed Akbari, Gaurav Shukla, Chaitra Badve, Jeffrey D. Rudie, Chiharu Sako, Saima Rathore, Spyridon Bakas, Sarthak Pati, Ashish Singh, Mark Bergman, Sung Min Ha, Despina Kontos, MacLean Nasrallah, Stephen J. Bagley, Robert A. Lustig, Donald M. O’Rourke, Andrew E. Sloan, Jill S. Barnholtz-Sloan, Suyash Mohan, Michel Bilello, Christos Davatzikos

JCO Clinical Cancer Informatics 2020 4
The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update

Paige Lundy, Joseph Domino, Timothy Ryken, Sarah Fouke, David J. McCracken, D. Ryan Ormond, Jeffrey J. Olson

Journal of Neuro-Oncology 2020 150 2
Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme

Andrew Elson, Eric Paulson, Joseph Bovi, Malika Siker, Chris Schultz, Peter S. Laviolette

Journal of Neuro-Oncology 2015 123 1
Thermal dose fractionation affects tumour physiological response

Donald E. Thrall, Paolo Maccarini, Paul Stauffer, James Macfall, Marlene Hauck, Stacey Snyder, Beth Case, Keith Linder, Lan Lan, Linda Mccall, Mark W. Dewhirst

International Journal of Hyperthermia 2012 28 5
Histogram Analysis of Diffusion Weighted Imaging in Low-Grade Gliomas: in vivo Characterization of Tumor Architecture and Corresponding Neuropathology

Georg Alexander Gihr, Diana Horvath-Rizea, Elena Hekeler, Oliver Ganslandt, Hans Henkes, Karl-Titus Hoffmann, Cordula Scherlach, Stefan Schob

Frontiers in Oncology 2020 10
Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy

R. Farjam, C. I. Tsien, F. Y. Feng, D. Gomez-Hassan, J. A. Hayman, T. S. Lawrence, Y. Cao

Neuro-Oncology 2014 16 1
The predictive capacity of apparent diffusion coefficient (ADC) in response assessment of brain metastases following radiation

Raphael Jakubovic, Stephanie Zhou, Chris Heyn, Hany Soliman, Liyang Zhang, Richard Aviv, Arjun Sahgal

Clinical & Experimental Metastasis 2016 33 3
Brain Edema XV

Shingo Takano, Hidehiro Kimu, Kyoji Tsuda, Satoru Osuka, Kei Nakai, Tetsuya Yamamoto, Eiichi Ishikawa, Hiroyoshi Akutsu, Masahide Matsuda, Akira Matsumura

2013 118
Diffusion-Weighted MR Imaging and MGMT Methylation Status in Glioblastoma: A Reappraisal of the Role of Preoperative Quantitative ADC Measurements

A. Gupta, A. Prager, R.J. Young, W. Shi, A.M.P. Omuro, J.J. Graber

American Journal of Neuroradiology 2013 34 1
Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma

Aurélien Corroyer-Dulmont, Elodie A. Pérès, Aurélie N. Gérault, Ariel Savina, Fanny Bouquet, Didier Divoux, Jérôme Toutain, Méziane Ibazizène, Eric T. MacKenzie, Louisa Barré, Myriam Bernaudin, Edwige Petit, Samuel Valable

European Journal of Nuclear Medicine and Molecular Imaging 2016 43 4
Current Role of Anti-Angiogenic Strategies for Glioblastoma

Alissa A. Thomas, Antonio Omuro

Current Treatment Options in Oncology 2014 15 4
Advanced Magnetic Resonance Imaging Methods for Planning and Monitoring Radiation Therapy in Patients With High-Grade Glioma

Seminars in Radiation Oncology 2014 24 4
Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics—A Systematic Review

Valentina Brancato, Silvia Nuzzo, Liberatore Tramontano, Gerolama Condorelli, Marco Salvatore, Carlo Cavaliere

Cancers 2020 12 10
Clustering Functional Magnetic Resonance Imaging Time Series in Glioblastoma Characterization: A Review of the Evolution, Applications, and Potentials

Matteo De Simone, Giorgio Iaconetta, Giuseppina Palermo, Alessandro Fiorindi, Karl Schaller, Lucio De Maria

Brain Sciences 2024 14 3
Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects

Federico Nemmi, Laure Saint-Aubert, Djilali Adel, Anne-Sophie Salabert, Jérémie Pariente, Emmanuel J. Barbeau, Pierre Payoux, Patrice Péran

European Journal of Nuclear Medicine and Molecular Imaging 2014 41 7
Diffusion Weighted Imaging in Gliomas: A Histogram-Based Approach for Tumor Characterization

Georg Gihr, Diana Horvath-Rizea, Patricia Kohlhof-Meinecke, Oliver Ganslandt, Hans Henkes, Wolfgang Härtig, Aneta Donitza, Martin Skalej, Stefan Schob

Cancers 2022 14 14
Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review

Jiahao Su, Meiqin Cai, Wensheng Li, Bo Hou, Haiyong He, Cong Ling, Tengchao Huang, Huijiao Liu, Ying Guo

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016 24 2
Apparent diffusion coefficient histogram analysis for prediction of prognosis in glioblastoma

Masatoshi Kondo, Yoshikazu Uchiyama

Journal of Neuroradiology 2018 45 4
Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature

Yuan Su, Wei-Bing Yang, Shi Li, Zhi-Jian Ye, Huan-Zhong Shi, Qiong Zhou, Yihai Cao

PLoS ONE 2012 7 4
Histogram Analysis of Diffusion Tensor Imaging Parameters in Pediatric Cerebellar Tumors

Matthias W. Wagner, Anand K. Narayan, Thangamadhan Bosemani, Thierry A.G.M. Huisman, Andrea Poretti

Journal of Neuroimaging 2016 26 3
Imaging biomarkers for antiangiogenic therapy in malignant gliomas

Kevin Leu, Whitney B Pope, Timothy F Cloughesy, Albert Lai, Phioanh L Nghiemphu, Wei Chen, Linda M Liau, Benjamin M Ellingson

CNS Oncology 2013 2 1
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction

Giuseppe Lombardi, Alessandro Spimpolo, Sara Berti, Cristina Campi, Maria Giulia Anglani, Rossella Simeone, Laura Evangelista, Francesco Causin, Giovanni Zorzi, Giancarlo Gorgoni, Mario Caccese, Marta Padovan, Vittorina Zagonel, Diego Cecchin

The British Journal of Radiology 2022 95 1129
Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan

Domenico Aquino, Anna Luisa Di Stefano, Alessandro Scotti, Lucia Cuppini, Elena Anghileri, Gaetano Finocchiaro, Maria Grazia Bruzzone, Marica Eoli, Russell O. Pieper

PLoS ONE 2014 9 3
Predictive markers for MGMT promoter methylation in glioblastomas

Tokunori Kanazawa, Yasuhiro Minami, Masahiro Jinzaki, Masahiro Toda, Kazunari Yoshida, Hikaru Sasaki

Neurosurgical Review 2019 42 4
Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis

M.S. Aboian, E. Tong, D.A. Solomon, C. Kline, A. Gautam, A. Vardapetyan, B. Tamrazi, Y. Li, C.D. Jordan, E. Felton, B. Weinberg, S. Braunstein, S. Mueller, S. Cha

American Journal of Neuroradiology 2019
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis

R. Kurokawa, A. Baba, M. Kurokawa, A. Capizzano, O. Hassan, T. Johnson, Y. Ota, J. Kim, A. Hagiwara, T. Moritani, A. Srinivasan

American Journal of Neuroradiology 2022 43 2
Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma

Maria Consuelo Valentini, Marta Mellai, Laura Annovazzi, Antonio Melcarne, Tetyana Denysenko, Paola Cassoni, Cristina Casalone, Cristiana Maurella, Silvia Grifoni, Piercarlo Fania, Angelina Cistaro, Davide Schiffer

Oncotarget 2017 8 53
Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma

Allison F. O’Neill, Lei Qin, Patrick Y. Wen, John F. de Groot, Annick D. Van den Abbeele, Jeffrey T. Yap

Journal of Neuro-Oncology 2016 130 3
Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse

Timo A. Auer, Hanns-Christian Breit, Federico Marini, Mirjam Renovanz, Florian Ringel, Clemens J. Sommer, Marc A. Brockmann, Yasemin Tanyildizi

Journal of Neuroradiology 2019 46 1
Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma

Carrie R. McDonald, Rachel L. Delfanti, Anitha P. Krishnan, Kelly M. Leyden, Jona A. Hattangadi-Gluth, Tyler M. Seibert, Roshan Karunamuni, Pia Elbe, Joshua M. Kuperman, Hauke Bartsch, David E. Piccioni, Nathan S. White, Anders M. Dale, Nikdokht Farid

Neuro-Oncology 2016
Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme

Francesco Buemi, Giuseppe Guzzardi, Bruno Del Sette, Andrea P Sponghini, Roberta Matheoud, Eleonora Soligo, Alessandra Trisoglio, Alessandro Carriero, Alessandro Stecco

The Neuroradiology Journal 2019 32 4
Correlation of diffusion MRI with the Ki-67 index in non-small cell lung cancer

Adem Karaman, Irmak Durur-Subasi, Fatih Alper, Omer Araz, Mahmut Subasi, Elif Demirci, Mevlut Albayrak, Gökhan Polat, Metin Akgun, Nevzat Karabulut

Radiology and Oncology 2015 49 3
Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab

A. Hilario, J. M. Sepulveda, A. Hernandez-Lain, E. Salvador, L. Koren, R. Manneh, Y. Ruano, A. Perez-Nuñez, A. Lagares, A. Ramos

Clinical and Translational Oncology 2017 19 1
Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization

Yan Luo, Ankur Pandey, Mounes Aliyari Ghasabeh, Pallavi Pandey, Farnaz Najmi Varzaneh, Manijeh Zarghampour, Pegah Khoshpouri, Sanaz Ameli, Zhen Li, Daoyu Hu, Ihab R. Kamel

European Radiology 2019 29 10
Apparent Diffusion Coefficient as a Predictive Biomarker for Survival in Patients with Treatment-Naive Glioblastoma Using Quantitative Multiparametric Magnetic Resonance Profiling

Byung Sup Kim, Sung Tae Kim, Joon Hyung Kim, Ho Jun Seol, Do-Hyun Nam, Hyung Jin Shin, Jung-Il Lee, Doo-Sik Kong

World Neurosurgery 2019 122
Diffusion-weighted MRI in neuro-oncology

Joachim M Baehring, Robert K Fulbright

CNS Oncology 2012 1 2
Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report

Motoo Nagane, Keiichi Kobayashi, Masaki Tanaka, Kazuhiro Tsuchiya, Yukiko Shishido-Hara, Saki Shimizu, Yoshiaki Shiokawa

International Journal of Clinical Oncology 2014 19 1
Volumetric voxelwise apparent diffusion coefficient histogram analysis for differentiation of the fourth ventricular tumors

Seyedmehdi Payabvash, Tarik Tihan, Soonmee Cha

The Neuroradiology Journal 2018 31 6
MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas

Vilde Elisabeth Mikkelsen, Hong Yan Dai, Anne Line Stensjøen, Erik Magnus Berntsen, Øyvind Salvesen, Ole Solheim, Sverre Helge Torp

Journal of Neuropathology & Experimental Neurology 2020 79 8
A bispecific antibody (ScBsAbAgn-2/TSPO) target for Ang-2 and TSPO resulted in therapeutic effects against glioblastomas

Jia Li, Zhiming Zhang, Lianjie Lv, Haibo Qiao, Xiuju Chen, Changlin Zou

Biochemical and Biophysical Research Communications 2016 472 2
Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile

Georg Gihr, Diana Horvath-Rizea, Elena Hekeler, Oliver Ganslandt, Hans Henkes, Karl-Titus Hoffmann, Cordula Scherlach, Stefan Schob, Gayle E. Woloschak

PLOS ONE 2021 16 4
Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery

Amir Zolal, Tareq A. Juratli, Jennifer Linn, Dino Podlesek, Kerim Hakan Sitoci Ficici, Hagen H. Kitzler, Gabriele Schackert, Stephan B. Sobottka, Bernhard Rieger, Dietmar Krex

Journal of Neuro-Oncology 2016 127 3
18F-Fluorodeoxyglucose and 11C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas

Hongyoon Choi, Ji-In Bang, Gi Jeong Cheon, Yong Hwy Kim, Chul-Kee Park, Sung-Hye Park, Keon Wook Kang, June-Key Chung, Euishin E. Kim, Dong Soo Lee

Nuclear Medicine Communications 2015 36 3
Multimodal Magnetic Resonance Imaging Evaluation of Primary Brain Tumors

Daniel Treister, Sara Kingston, Kristina E. Hoque, Meng Law, Mark S. Shiroishi

Seminars in Oncology 2014 41 4
Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI

Z. Xing, W. Huang, Y. Su, X. Yang, X. Zhou, D. Cao

Clinical Radiology 2022 77 8
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial

Marianne Schell, Irada Pflüger, Gianluca Brugnara, Fabian Isensee, Ulf Neuberger, Martha Foltyn, Tobias Kessler, Felix Sahm, Antje Wick, Martha Nowosielski, Sabine Heiland, Michael Weller, Michael Platten, Klaus H Maier-Hein, Andreas Von Deimling, Martin J Van Den Bent, Thierry Gorlia, Wolfgang Wick, Martin Bendszus, Philipp Kickingereder

Neuro-Oncology 2020 22 11
Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?

Natalie R Boonzaier, Sara GM Piccirillo, Colin Watts, Stephen J Price

CNS Oncology 2015 4 6
Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging

Hye Rim Cho, Nisha Kumari, Nishant Thakur, Hien Thi Vu, Hyeonjin Kim, Seung Hong Choi

Scientific Reports 2019 9 1
Diffusion Tensor Histogram Analysis of Pediatric Diffuse Intrinsic Pontine Glioma

Emilie A. Steffen-Smith, Joelle E. Sarlls, Carlo Pierpaoli, Joanna H. Shih, Robyn S. Bent, Lindsay Walker, Katherine E. Warren

BioMed Research International 2014 2014
Diffusion imaging could aid to differentiate between glioma progression and treatment-related abnormalities: a meta-analysis

Rik van den Elshout, Tom W. J. Scheenen, Chantal M. L. Driessen, Robert J. Smeenk, Frederick J. A. Meijer, Dylan Henssen

Insights into Imaging 2022 13 1
Diffusion kurtosis imaging combined with molecular markers as a comprehensive approach to predict overall survival in patients with gliomas

Xuan Wang, Fuyan Li, Dawei Wang, Qingshi Zeng

European Journal of Radiology 2020 128
Apparent Diffusion Coefficient as Imaging Biomarker for Identifying IDH Mutation, 1p19q Codeletion, and MGMT Promoter Methylation Status in Patients With Glioma

Xiaoxiao Ma, Kun Cheng, Gang Cheng, Chenxi Li, Jinhao Lyu, Yina Lan, Caohui Duan, Xiangbing Bian, Jianning Zhang, Xin Lou

Journal of Magnetic Resonance Imaging 2023 58 3
Gliomas

Whitney B. Pope, Ibrahim Djoukhadar, Alan Jackson

2016 134
Imaging acute effects of bevacizumab on tumor vascular kinetics in a preclinical orthotopic model of U251 glioma

Tavarekere N. Nagaraja, Rasha Elmghirbi, Stephen L. Brown, Julian A. Rey, Lonni Schultz, Abir Mukherjee, Glauber Cabral, Swayamprava Panda, Ian Y. Lee, Malisa Sarntinoranont, Kelly A. Keenan, Robert A. Knight, James R. Ewing

NMR in Biomedicine 2021 34 7
Advanced MR Imaging in Neuro-oncology

A. Radbruch, M. Bendszus

Clinical Neuroradiology 2015 25 S2
Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab

Cheng Hong Toh, Chi-Ting Liau, Kuo-Chen Wei, Mauricio Castillo

Journal of Neuro-Oncology 2019 142 1
Diffusion MR Imaging of the Brain in Patients with Cancer

J. Matthew Debnam, Dawid Schellingerhout

International Journal of Molecular Imaging 2011 2011
Functional Brain Tumor Imaging

Sumei Wang, Sungheon Kim, Elias R. Melhem

2014
Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas

E. Lin, T. Scognamiglio, Y. Zhao, T.H. Schwartz, C.D. Phillips

American Journal of Neuroradiology 2018
Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes

Francesco D’Amore, Farida Grinberg, Jörg Mauler, Norbert Galldiks, Ganna Blazhenets, Ezequiel Farrher, Christian Filss, Gabriele Stoffels, Felix M Mottaghy, Philipp Lohmann, Nadim Jon Shah, Karl-Josef Langen

Neuro-Oncology Advances 2021 3 1
Dynamic susceptibility contrast and diffusion‐weighted MRI in posterior fossa pilocytic astrocytoma and medulloblastoma

Ryo Kurokawa, Yoshie Umemura, Aristides Capizzano, Mariko Kurokawa, Akira Baba, Adam Holmes, John Kim, Yoshiaki Ota, Ashok Srinivasan, Toshio Moritani

Journal of Neuroimaging 2022 32 3
Magnetic resonance diffusion metrics indexing high focal cellularity and sharp transition at the tumour boundary predict poor outcome in glioblastoma multiforme

A.A.B. Jamjoom, D. Rodriguez, A.T. Rajeb, M.A. Manita, K.A. Shah, D.P. Auer

Clinical Radiology 2015 70 12
The Accuracy of ADC Measurements in Liver Is Improved by a Tailored and Computationally Efficient Local-Rigid Registration Algorithm

Hossein Ragheb, Neil A. Thacker, Jean-Marie Guyader, Stefan Klein, Nandita M. deSouza, Alan Jackson, Jie Tian

PLOS ONE 2015 10 7
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab

Alissa Thomas, Marc Rosenblum, Sasan Karimi, Lisa M DeAngelis, Antonio Omuro, Thomas J Kaley

CNS Oncology 2018 7 1
ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma

Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez, Pedro Galán Montenegro

Acta Radiologica 2020 61 3
Analysis of T2 signal intensity helps in the differentiation between high and low-grade brain tumours in paediatric patients

Stephanie Lescher, Ketan Whora, Dirk Schwabe, Matthias Kieslich, Luciana Porto

European Journal of Paediatric Neurology 2016 20 1
Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment

Hye Hyeon Moon, Ji Eun Park, Young-Hoon Kim, Jeong Hoon Kim, Ho Sung Kim

Journal of Neuro-Oncology 2022 157 3
Correlation Analysis of Apparent Diffusion Coefficient Histogram Parameters and Clinicopathologic Features for Prognosis Prediction in Uveal Melanoma

Yue Zheng, Yan Tang, Yiran Yao, Tongxin Ge, Hui Pan, Junqi Cui, Yamin Rao, Xiaofeng Tao, Renbing Jia, Songtao Ai, Xin Song, Ai Zhuang

Investigative Ophthalmology & Visual Science 2024 65 8
Diffusion-Weighted MR Imaging of the Brain, Head and Neck, and Spine

Jayapalli Rajiv Bapuraj, Toshio Moritani, Shotaro Naganawa, Akio Hiwatashi, Christopher Becker, Yoshie Umemura, Michelle M. Kim

2021
Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy

Xiaorui Su, Xibiao Yang, Huaiqiang Sun, Yanhui Liu, Ni Chen, Shuang Li, Zongyao Huang, Hanbing Shao, Simin Zhang, Qiyong Gong, Qiang Yue

Journal of Magnetic Resonance Imaging 2024 59 2
From K-space to Nucleotide

Nabil Elshafeey, Islam Hassan, Pascal O. Zinn, Rivka R. Colen

Topics in Magnetic Resonance Imaging 2017 26 1
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial

Sied Kebir, Christina Schaub, Nina Junold, Elke Hattingen, Niklas Schäfer, Joachim P. Steinbach, Astrid Weyerbrock, Peter Hau, Roland Goldbrunner, Norbert Galldiks, Johannes Weller, Frederic Mack, Theophilos Tzaridis, Oliver Bähr, Clemens Seidel, Uwe Schlegel, Friederike Schmidt-Graf, Veit Rohde, Christian Borchers, Ghazaleh Tabatabai, Mathias Hänel, Michael Sabel, Rüdiger Gerlach, Dietmar Krex, Claus Belka, Hartmut Vatter, Martin Proescholdt, Martin Glas, Ulrich Herrlinger

Journal of Neuro-Oncology 2019 144 3
Comparative Histologic and Molecular Analysis of 2 Recurrent Lesions Showing Different Magnetic Resonance Imaging Responses After Bevacizumab Treatment: Report of a Case of Anaplastic Astrocytoma

Yoshihiro Otani, Tomotsugu Ichikawa, Atsuhito Uneda, Kazuhiko Kurozumi, Joji Ishida, Isao Date

World Neurosurgery 2018 116
Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis

Zuo-cheng Yang, Chuan-dong Yin, Fang-cheng Yeh, Bo-wen Xue, Xin-yu Song, Gen Li, Sheng-jun Sun, Zheng-hai Deng, Zong-gang Hou, Jian Xie

Journal of Neuro-Oncology 2024 166 1
Functional Neuroradiology

Shah Islam, Melanie A. Morrison, Adam D. Waldman

2023
Neurorehabilitation in Neuro-Oncology

Giuseppe Minniti, Andrea Romano, Claudia Scaringi, Alessandro Bozzao

2019
Use of the measured diffusion coefficient for predicting overall and progression-free survival rates in patients with recurrent glioblastoma treated with bevacizumab

I.A. Stepanov, V.A. beloborodov, M.A. Shameeva, E.B. Borisov, I.A. Shagdurova

Onkologiya. Zhurnal imeni P.A.Gertsena 2020 9 6
Advanced Distance-Resolved Evaluation of the Perienhancing Tumor Areas with FLAIR Hyperintensity Indicates Different ADC Profiles byMGMTPromoter Methylation Status in Glioblastoma

Gergely Bertalan, Nicolin Hainc, Fabian Dominik Von Dehn, Tibor Hortobágyi, Andrea Bink, Emilie Le Rhun, Michael Weller, Zsolt Kulcsar

American Journal of Neuroradiology 2025 46 2
Advanced neuroimaging techniques for diagnosis and treatment evaluation in neuro-oncology

Bernhard Schuknecht, Krisztina Baráth, Silvia Hofer

memo - Magazine of European Medical Oncology 2012 5 3
Auf dem Weg zu mehr Präzision in der Hirntumortherapie

A. Radbruch, E. Hattingen

Der Nervenarzt 2015 86 6
Brain Tumor Imaging

Peter Raab, Heinrich Lanfermann

2015
Characterization of Diffusion Metric Map Similarity in Data From a Clinical Data Repository Using Histogram Distances

Graham C. Warner, Karl G. Helmer

Frontiers in Neuroscience 2018 12
Diffusion imaging in gliomas: how ADC values forecast glioma genetics

Paulina Śledzińska-Bebyn, Jacek Furtak, Marek Bebyn, Alicja Bartoszewska-Kubiak, Zbigniew Serafin

Polish Journal of Radiology 2025 90
Drug Delivery Applications of Noninvasive Imaging

Edward F. Jackson

2013
Functional Imaging in Oncology

L. Celso Hygino da Cruz, Raquel Ribeiro Batista, Claudio de Carvalho Rangel

2014
Functional Neuroradiology

Prem P. Batchala, Thomas J. Eluvathingal Muttikkal, Joseph H. Donahue, M. Beatriz Lopes, Eli S. Williams, Nicholas J. Tustison, Sohil H. Patel

2023
Glioma Imaging

Michael Cardenas, Craig J. Galban, Thomas L. Chenevert, Michelle Miller-Thomas, Brian D. Ross, Christina Tsien

2020
Handbook of Neuro-Oncology Neuroimaging

Diogo Goulart Corrêa, Luiz Celso Hygino da Cruz

2022
Radiogenomics of Oncology

Jason Chiang, Neema Jamshidi

Advances in Clinical Radiology 2019 1
Sample strategies for the assessment of the apparent diffusion coefficient in single large intracranial space-occupying lesions of dogs and cats

Tatjana Chan, Henning Richter, Francesca Del Chicca

Frontiers in Veterinary Science 2024 11
Texture Analysis of the Apparent Diffusion Coefficient Focused on Contrast-Enhancing Lesions in Predicting Survival for Bevacizumab-Treated Patients with Recurrent Glioblastoma

Antonio Lopez-Rueda, Josep Puig, Santiago Thió-Henestrosa, Javier Luis Moreno-Negrete, Christian Zwanzger, Teresa Pujol, Iban Aldecoa, Estela Pineda, Izaskun Valduvieco, José Juan González, Laura Oleaga

Cancers 2023 15 11

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 32, Issue 5

1 May 2011

Table of Contents
Index by author

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

W.B. Pope, A. Lai, R. Mehta, H.J. Kim, J. Qiao, J.R. Young, X. Xue, J. Goldin, M.S. Brown, P.L. Nghiemphu, A. Tran, T.F. Cloughesy

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

American Journal of Neuroradiology May 2011, 32 (5) 882-889; DOI: 10.3174/ajnr.A2385

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

W.B. Pope, A. Lai, R. Mehta, H.J. Kim, J. Qiao, J.R. Young, X. Xue, J. Goldin, M.S. Brown, P.L. Nghiemphu, A. Tran, T.F. Cloughesy

American Journal of Neuroradiology May 2011, 32 (5) 882-889; DOI: 10.3174/ajnr.A2385

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Info & Metrics
Responses
References
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Advanced Distance-Resolved Evaluation of the Perienhancing Tumor Areas with FLAIR Hyperintensity Indicates Different ADC Profiles by MGMT Promoter Methylation Status in Glioblastoma
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis
Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis
Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas
Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival
Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
Diffusion-Weighted MR Imaging and MGMT Methylation Status in Glioblastoma: A Reappraisal of the Role of Preoperative Quantitative ADC Measurements
Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors?

Crossref (154)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging

Nathan S. White, Carrie R. McDonald, Niky Farid, Josh Kuperman, David Karow, Natalie M. Schenker-Ahmed, Hauke Bartsch, Rebecca Rakow-Penner, Dominic Holland, Ahmed Shabaik, Atle Bjørnerud, Tuva Hope, Jona Hattangadi-Gluth, Michael Liss, J. Kellogg Parsons, Clark C. Chen, Steve Raman, Daniel Margolis, Robert E. Reiter, Leonard Marks, Santosh Kesari, Arno J. Mundt, Christopher J. Kane, Bob S. Carter, William G. Bradley, Anders M. Dale

Cancer Research 2014 74 17
Imaging Correlates of Adult Glioma Genotypes

Marion Smits, Martin J. van den Bent

Radiology 2017 284 2
Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

Christine Lu-Emerson, Dan G. Duda, Kyrre E. Emblem, Jennie W. Taylor, Elizabeth R. Gerstner, Jay S. Loeffler, Tracy T. Batchelor, Rakesh K. Jain

Journal of Clinical Oncology 2015 33 10
Quantifying heterogeneity in human tumours using MRI and PET

Marie-Claude Asselin, James P.B. O’Connor, Ronald Boellaard, Neil A. Thacker, Alan Jackson

European Journal of Cancer 2012 48 4
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI

S. Wang, M. Martinez-Lage, Y. Sakai, S. Chawla, S.G. Kim, M. Alonso-Basanta, R.A. Lustig, S. Brem, S. Mohan, R.L. Wolf, A. Desai, H. Poptani

American Journal of Neuroradiology 2016 37 1
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T

Daniel Paech, Johannes Windschuh, Johanna Oberhollenzer, Constantin Dreher, Felix Sahm, Jan-Eric Meissner, Steffen Goerke, Patrick Schuenke, Moritz Zaiss, Sebastian Regnery, Sebastian Bickelhaupt, Philipp Bäumer, Martin Bendszus, Wolfgang Wick, Andreas Unterberg, Peter Bachert, Mark Edward Ladd, Heinz-Peter Schlemmer, Alexander Radbruch

Neuro-Oncology 2018 20 12
Relationship Between Imaging Biomarkers of Stage I Cervical Cancer and Poor-Prognosis Histologic Features: Quantitative Histogram Analysis of Diffusion-Weighted MR Images

Kate Downey, Sophie F. Riches, Veronica A. Morgan, Sharon L. Giles, Ayoma D. Attygalle, Tom E. Ind, Desmond P. J. Barton, John H. Shepherd, Nandita M. deSouza

American Journal of Roentgenology 2013 200 2
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas

Kevin Leu, Garrett A. Ott, Albert Lai, Phioanh L. Nghiemphu, Whitney B. Pope, William H. Yong, Linda M. Liau, Timothy F. Cloughesy, Benjamin M. Ellingson

Journal of Neuro-Oncology 2017 134 1
Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma

Yi‐bin Xi, Fan Guo, Zi‐liang Xu, Chen Li, Wei Wei, Ping Tian, Ting‐ting Liu, Lin Liu, Gang Chen, Jing Ye, Guang Cheng, Long‐biao Cui, Hong‐juan Zhang, Wei Qin, Hong Yin

Journal of Magnetic Resonance Imaging 2018 47 5
Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics

Benjamin M. Ellingson

Current Neurology and Neuroscience Reports 2015 15 1

Main menu

User menu

Search

American Journal of Neuroradiology

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

Article Information

Author Information

Altmetrics

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Indexed Content

Cases

Special Collections

Resources

Multimedia

About Us

American Society of Neuroradiology